Partner Diagnostic Network

Not every diagnostic service needs to be located in one place. A longevity platform can also function as a trusted network.

Advanced longevity diagnostics requires many different capabilities. Some can be developed locally. Others require specialized laboratories, imaging centers, clinical expertise, research environments, or international partners.

High Coast Longevity is being developed as a platform that can combine its own environment with selected external expertise. This makes it possible to build a broader diagnostic model without claiming to provide every service directly at High Coast.

The long-term goal is to create a network where relevant technologies can be evaluated, integrated, and translated into meaningful guidance.

Why a partner network matters

Longevity diagnostics is too broad for one location to do everything alone.

A partner model may support:

• broader diagnostic access
• specialized expertise
• advanced imaging
• laboratory testing
• clinical interpretation
• research collaboration
• international development

This makes the platform more flexible and scalable.

Imaging partners

Imaging requires specialized infrastructure and medical expertise.

Potential partner areas include:

• MRI
• CT
• ultrasound
• DEXA
• cardiovascular imaging
• organ-specific imaging
• body composition analysis

These services may be integrated through selected partners when they support meaningful diagnostic insight.

Laboratory partners

Laboratory testing is central to diagnostics.

Potential partner areas include:

• blood biomarkers
• inflammatory markers
• metabolic markers
• hormonal panels
• genetic testing
• epigenetic testing
• microbiome analysis
• advanced omics

The goal is to work with laboratories that meet appropriate standards and provide interpretable results.

Clinical partners

Some findings require clinical evaluation.

Partner relationships may include:

• physicians
• specialists
• preventive medicine clinics
• cardiology providers
• endocrinology expertise
• functional assessment providers
• rehabilitation and performance specialists

This helps ensure that diagnostic insights can be interpreted responsibly.

Digital health partners

Digital platforms may support monitoring, tracking, and interpretation.

Potential partner areas include:

• wearable data platforms
• sensor technology
• health dashboards
• AI-supported interpretation
• continuous glucose monitoring
• remote follow-up tools
• longitudinal data systems

Digital partners may help connect everyday data with diagnostic follow-up.

Research partners

Research collaboration can help improve the platform over time.

Potential collaborations may include:

• universities
• research groups
• clinical studies
• nutrition research
• biomarker validation
• Nordic berry research
• longevity science projects

This is important for moving from science-backed communication toward evidence generation.

International pathways

Some advanced diagnostics or longevity technologies may be more available outside the local region.

A future partner network may connect users with:

• clinics in Sweden
• Nordic diagnostic providers
• European partners
• international longevity centers
• specialized technology providers

This allows the platform to grow beyond one physical place.

Standards for integration

Not every partner or technology should be included.

High Coast Longevity should evaluate partners according to:

• scientific credibility
• quality standards
• transparency
• data security
• clinical responsibility
• user value
• interpretability
• long-term relevance

The goal is a trusted network, not a collection of disconnected services.

Current stage

The partner diagnostic network is part of the long-term platform model.

High Coast Longevity is developing the structure, language, and evaluation principles for future collaboration. The purpose is to build a credible ecosystem where diagnostics, science, technology, and guidance can work together over time.